NCT01849783View on ClinicalTrials.gov

Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

April 4, 2013

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Extramedullary PlasmacytomaIsolated Plasmacytoma of BoneLight Chain Deposition DiseasePrimary Systemic AmyloidosisStage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
Interventions
DRUG

dexamethasone

Given PO

DRUG

cisplatin

Given IV

DRUG

doxorubicin

Given IV

DRUG

cyclophosphamide

Given IV or PO

DRUG

etoposide

Given IV

DRUG

bortezomib

Given IV

DRUG

thalidomide

Given PO

DRUG

melphalan

Given IV

PROCEDURE

autologous stem cell transplant

Trial Locations (1)

52242

University of Iowa Hospitals and Clinics, Iowa City

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Margarida Magalhaes-Silverman

OTHER

NCT01849783 - Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter